Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Total Current Liabilities (2021 - 2025)

LifeStance Health (LFST) has disclosed Total Current Liabilities for 5 consecutive years, with $252.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 10.08% to $252.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $252.0 million, a 10.08% increase, with the full-year FY2025 number at $252.0 million, up 10.08% from a year prior.
  • Total Current Liabilities was $252.0 million for Q4 2025 at LifeStance Health, up from $228.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $252.0 million in Q4 2025 to a low of $105.2 million in Q3 2021.
  • A 5-year average of $183.0 million and a median of $202.9 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 114.55% in 2023, then dropped 9.7% in 2024.
  • LifeStance Health's Total Current Liabilities stood at $116.8 million in 2021, then surged by 50.75% to $176.0 million in 2022, then rose by 15.27% to $202.9 million in 2023, then grew by 12.82% to $228.9 million in 2024, then rose by 10.08% to $252.0 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Total Current Liabilities are $252.0 million (Q4 2025), $228.6 million (Q3 2025), and $242.3 million (Q2 2025).